drugset / Trial / NCT01295645
Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis
RandomizedSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to learn if adding cidofovir to the standard of care can improve symptoms of hemorrhagic cystitis caused by the BK virus as compared to standard of care alone. The safety of cidofovir will also be studied.
Timeline
- Start
- 2011-03-17
- Primary completion
- 2028-03-15
- Completion
- 2028-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CIDOFOVIR ANHYDROUS | Small molecule | 0.5 mg/kg | Intravenous |